MobiHealth News March 8, 2024
The patch provides continuous glucose monitoring, sends readings directly to a wearer’s smartphone and supplies personal insights into one’s glucose health.
An over-the-counter continuous glucose monitoring (CGM) solution developed by Dexcom called Stelo has received clearance from the Food and Drug Administration (FDA).
Available without the need for a prescription, the wearable biosensor boasts a battery life of up to two weeks and adheres to the back of the upper arm.
The patch aids in the detection of normal (euglycemic) as well as low or high (dysglycemic) glucose levels.
It provides round-the-clock glucose readings directly to a smartphone and delivers personalized insights into glucose health, offering users actionable information to make informed decisions.
Tailored for individuals 18 and up...
Today's Sponsors
Today's Sponsor